<?xml version="1.0" encoding="UTF-8"?>
<ref id="B138">
 <label>138.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Monteil</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Kwon</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Prado</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Hagelkrüys</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Wimmer</surname>
    <given-names>RA</given-names>
   </name>
   <name>
    <surname>Stahlet</surname>
    <given-names>M</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2.</article-title>
  <source>
   <italic>Cell.</italic>
  </source> (
  <year>2020</year>) 
  <volume>181</volume>:
  <fpage>905</fpage>–
  <lpage>13.e7</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.cell.2020.04.004</pub-id>
  <?supplied-pmid 32333836?>
  <pub-id pub-id-type="pmid">32333836</pub-id>
 </mixed-citation>
</ref>
